BPC-157 and TB-500 Stack: Dosing, Timing & What to Expect

Introduction

The standard BPC-157 and TB-500 stack runs BPC-157 at 250 to 500 mcg once or twice daily and TB-500 at 2 to 5 mg once or twice weekly, for a cycle of 6 to 12 weeks. That’s the protocol most compounding pharmacies and peptide-literate providers use, and it’s the answer most readers came for. The rest of this article covers the details that actually determine whether the experiment is worth running: timing, injection logistics, realistic expectations, side effects, and sourcing.

One framing note before the practical content. These dosing conventions come from clinical practice patterns and user communities, not from dose-finding trials, because no published human trial of either peptide exists as of mid-2026. The animal literature, much of it from Predrag Sikiric’s group in Zagreb for BPC-157 and from thymosin beta-4 research for TB-500, is encouraging and consistent. It is also not human proof. Run this stack, if you run it, with that understanding and with a licensed provider involved.

At TrimRx, we believe understanding your options is the first step toward a more manageable health journey. If you’d like a provider to weigh in on whether recovery peptides fit your plan, the free assessment quiz takes a few minutes.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Does Each Peptide Contribute?

BPC-157 brings growth factor and blood vessel support; TB-500 brings cell migration. BPC-157, a 15-amino-acid synthetic peptide derived from a gastric protein, improved healing in rodent models of tendon, ligament, muscle, and gut injury across dozens of published studies since the 1990s. TB-500 replicates the active fragment of thymosin beta-4, the actin-binding protein that helps repair cells physically move into damaged tissue.

Quick Answer: Standard stack dosing runs BPC-157 at 250 to 500 mcg daily and TB-500 at 2 to 5 mg weekly, cycled for 6 to 12 weeks.

The combination is popular because the mechanisms complement rather than duplicate each other. No controlled study has compared the stack against either peptide alone, so the additive benefit is mechanistic reasoning, not measured fact.

Standard Dosing Protocol

The most common protocol splits into a loading phase and a maintenance phase:

Some providers skip the front-load and run TB-500 at a flat 2.5 mg weekly. Others push BPC-157 to twice daily (morning and evening) for acute injuries. Total weekly TB-500 rarely exceeds 5 mg in sensible protocols, and BPC-157 rarely exceeds 1 mg daily.

Bodyweight-based dosing appears in older forum lore (around 2.5 to 10 mcg per kilogram for BPC-157), but most modern compounding protocols just use flat doses in the ranges above.

Injection Timing: When and How Often?

Consistency beats clock precision. BPC-157’s daily dose can go in at any consistent time; many users pick morning. For twice-daily protocols, space doses roughly 8 to 12 hours apart. TB-500’s weekly or twice-weekly doses just need even spacing, like Monday and Thursday.

Food doesn’t matter for injections. Training timing doesn’t have evidence behind it either way, though plenty of users inject post-training out of habit. If you remember nothing else: same time, same days, full cycle. Sporadic dosing makes a low-evidence experiment completely uninterpretable.

Can you mix both peptides in one syringe? Generally yes, and combined vials from compounding pharmacies do exactly that. If using separate vials, drawing both into one insulin syringe for a single subcutaneous shot is common practice. Inject into abdominal fat, rotating sites to avoid irritation.

Should You Inject Near the Injury?

Probably doesn’t matter, so go with comfort. The local-injection theory says peptide concentration near damaged tissue improves results. The counterargument is that subcutaneous peptides absorb into systemic circulation and travel everywhere regardless. Rodent studies used systemic dosing and still found effects at distant injury sites, which supports the “anywhere is fine” position.

Some practitioners still prefer dosing near (not into) the injured area for soft tissue cases. There’s no controlled comparison either way. Abdominal injections are easier, less painful, and lower-risk for self-administration, which is why most protocols default there.

What to Expect Week by Week

Set expectations low and specific. Pooled user reports and practitioner observations sketch this rough arc:

• Weeks 1 to 2: little or nothing. Some report reduced soreness or better sleep; injection routine gets established.
• Weeks 2 to 4: the most commonly reported window for noticing less pain in the problem area, especially tendons.
• Weeks 4 to 8: reported improvements in load tolerance, range of motion, and training consistency.
• Weeks 8 to 12: plateau territory; most protocols end here and reassess.

Now the necessary cold water. Soft tissue injuries improve naturally over 4 to 12 weeks, which is the exact window above. Without a control group, you cannot tell peptide effect from normal healing plus placebo. Track objective markers anyway (pain score during a standard movement, training loads, morning stiffness duration) so your end-of-cycle review is more than vibes.

Side Effects and What to Watch

Most users report nothing beyond minor injection site redness or itching. Smaller numbers report headache, transient fatigue, nausea, or a brief lightheaded feeling after TB-500 doses. These typically fade within the first week or two.

Stop and consult your provider if you see signs of infection at injection sites (spreading redness, warmth, pus), allergic response (hives, swelling, breathing trouble), or anything systemic and persistent. Sterile technique prevents the most common real-world problem, which is contamination from poor handling rather than the peptides themselves.

The long-term unknowns deserve one honest paragraph. Both peptides influence angiogenesis, the growth of new blood vessels, which is how healing tissue gets supplied and also how tumors feed. No human evidence connects either compound to cancer, and no long-term human safety study exists to rule it out. Anyone with an active or recent malignancy should stay away without oncology clearance. Pregnant and nursing women have zero safety data and should not use either peptide.

Key Takeaway: The two peptides can be drawn into one syringe or injected separately; both go subcutaneous for most users.

Legality, Testing, and the 2026 Regulatory Picture

The legal route in 2026 is a prescription filled by a licensed 503A compounding pharmacy. Neither peptide is an FDA-approved drug or a legal dietary supplement ingredient. BPC-157’s standing improved in April 2026 when the FDA removed it from the Category 2 bulk substances list, clearing the path for routine compounding under provider prescriptions. TB-500’s compounding status remains less settled, and some providers structure protocols around BPC-157 alone for that reason.

Telehealth programs that operate on the prescription-and-pharmacy model, such as TrimRx, FormBlends, and HealthRX.com, exist to keep this entire process inside the regulated lane: medical intake, provider review, pharmacy dispensing, and follow-up.

Athletes face a separate rule book. WADA prohibits BPC-157 (added to S0 in 2022) and thymosin beta-4 fragments. Detection methods exist for both. Tested athletes should treat this stack as radioactive.

Cost Breakdown

Through licensed compounding channels, expect roughly $100 to $250 per month depending on doses, combined versus separate vials, and pharmacy. A typical mid-range setup (250 mcg BPC-157 daily plus 2.5 mg TB-500 weekly) lands near $150 monthly. A full 12-week cycle therefore runs $300 to $750 including supplies.

Gray-market research vendors undercut those prices by half or more. Independent testing of such products has repeatedly found underdosing, mislabeling, and purity failures, which turns a cheap experiment into an unknowable one. For injectables, pharmacy-grade sourcing is the floor, not a luxury.

Insulin syringes (29 to 31 gauge), alcohol swabs, and bacteriostatic water for reconstitution add maybe $20 to a cycle.

Reconstitution and Storage Basics

Lyophilized peptides arrive as powder and need bacteriostatic water before use. A standard approach: add 2 mL of bacteriostatic water to a 5 mg BPC-157 vial, which yields 250 mcg per 0.1 mL on an insulin syringe. For a 5 mg TB-500 vial, 1 mL of water gives 2.5 mg per 0.5 mL. Inject the water slowly down the vial wall rather than blasting the powder, and swirl gently instead of shaking.

Reconstituted vials belong in the refrigerator and stay usable for roughly 4 weeks, sometimes longer per pharmacy guidance. Unreconstituted powder keeps for months refrigerated and longer frozen. Heat, sunlight, and repeated temperature swings degrade peptides, so leaving a vial on a windowsill or in a car undoes whatever quality you paid for.

Compounding pharmacies often ship pre-mixed, dated vials with exact draw instructions, which removes most of this math. That convenience is one more argument for the prescription route over powder from an anonymous website.

Common Mistakes That Waste a Cycle

Four errors account for most disappointed stack users. First, inconsistent dosing: skipping a third of your injections turns a 12-week protocol into noise. Second, no baseline measurement, which makes the end-of-cycle review pure feeling. Third, increasing training load too fast because the area “feels better” at week 3, re-injuring the tissue the stack was meant to support. Fourth, bargain sourcing, where the vial may contain a fraction of the labeled dose.

A fifth, subtler mistake is stacking too many new variables at once. If you start peptides, a new lifting program, creatine, and a deload all in the same month, nothing you observe is attributable to anything.

The Path Forward

Run this stack like a protocol, not a hobby: provider on board, pharmacy-sourced vials, fixed doses, a 6 to 12 week window, objective tracking, and a scheduled decision point at the end. That structure costs nothing extra and converts an internet trend into something resembling responsible self-experimentation.

TrimRx applies that same structure to everything we prescribe, from compounded GLP-1 medications to our expanding peptide offerings, with licensed providers reviewing every case before a pharmacy ships anything. If you want to know whether recovery peptides, a different therapy, or just better fundamentals fit your situation, start with the free assessment quiz.

Bottom line: Budget $100 to $250 monthly through licensed compounding pharmacies.

FAQ

Can I Mix BPC-157 and TB-500 in the Same Syringe?

Yes, this is common practice and combined vials from compounding pharmacies already blend them. If reconstituting separately, draw both into one insulin syringe and inject subcutaneously. Use bacteriostatic water for reconstitution and refrigerate vials.

How Long Until the BPC-157 and TB-500 Stack Works?

User reports most often describe noticeable change between weeks 2 and 4, with continued improvement to week 8. No human trial has verified these timelines, and natural healing follows a similar arc, so track objective measures rather than impressions.

Do I Need to Cycle Off the Stack?

Standard practice runs 6 to 12 weeks on, then at least 4 weeks off. Cycling is precautionary convention rather than trial-derived, reflecting the absence of long-term safety data for continuous use.

What’s the Best BPC-157 Dose for Injury Recovery?

Most protocols use 250 to 500 mcg daily, sometimes split into two doses for acute injuries. Doses above 1 mg daily offer no demonstrated advantage and just raise cost.

Is Subcutaneous or Intramuscular Injection Better?

Subcutaneous is the default: easier, less painful, and what most protocols assume. Some practitioners use intramuscular dosing near injured muscle, but no comparison study shows it outperforms subcutaneous delivery.

Will This Stack Trigger a Positive Drug Test?

In tested sport, yes, both compounds are WADA-prohibited and detectable. Standard employment drug screens don’t look for peptides.

Can I Run This Stack Alongside a GLP-1 Medication?

Providers commonly allow it since the mechanisms don’t conflict. GLP-1 drugs like semaglutide address weight (about 15 percent average loss in STEP 1, Wilding 2021, New England Journal of Medicine), while this stack targets tissue recovery. Clear any combination with your prescriber.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.